SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
Reinsurance Group of America, Incorporated
--------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $.01 Per Share
--------------------------------------------------------
(Title of Class of Securities)
759351109
--------------------------------------------------------
(CUSIP Number)
Gwenn L. Carr
MetLife, Inc.
One Madison Avenue
New York, New York 10010
(212)578-2211
--------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 24, 2003
--------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 25
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
MetLife, Inc.
13-4075851
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 2,532,600
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 29,710,939
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
2,532,600
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
29,710,939
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
32,243,539
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
53.3%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
-------------------------------------------------------------------------------
------------------------------
* This percentage is based upon the number of Shares issued and outstanding
as of October 31, 2003, as described in RGA's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003, as adjusted to give effect to the
public offering by RGA of 10,500,000 Shares (assuming no exercise of the
underwriters' over-allotment option).
Page 2 of 25
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Metropolitan Life Insurance Company
13-5581829
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 29,710,939
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
29,710,939
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
29,710,939
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
49.1%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IC
-------------------------------------------------------------------------------
------------------------------
* This percentage is based upon the number of Shares issued and outstanding
as of October 31, 2003, as described in RGA's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003, as adjusted to give effect to the
public offering by RGA of 10,500,000 Shares (assuming no exercise of the
underwriters' over-allotment option).
Page 3 of 25
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GenAmerica Financial Corporation
43-1779470
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,926,250
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,926,250
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,926,250
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.2%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
-------------------------------------------------------------------------------
------------------------------
* This percentage is based upon the number of Shares issued and outstanding
as of October 31, 2003, as described in RGA's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003, as adjusted to give effect to the
public offering by RGA of 10,500,000 Shares (assuming no exercise of the
underwriters' over-allotment option).
Page 4 of 25
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
General American Life Insurance Company
43-0285930
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,926,250
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,926,250
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,926,250
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.2%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IC
-------------------------------------------------------------------------------
------------------------------
* This percentage is based upon the number of Shares issued and outstanding
as of October 31, 2003, as described in RGA's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003, as adjusted to give effect to the
public offering by RGA of 10,500,000 Shares (assuming no exercise of the
underwriters' over-allotment option).
Page 5 of 25
SCHEDULE 13D CUSIP No. 759351109
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Equity Intermediary Company
43-1727895
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 SOURCE OF FUNDS
Not Applicable
-------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Missouri
-------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY ----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 24,926,250
WITH ----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,926,250
-------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,926,250
-------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
-------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.2%*
-------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
HC, CO
-------------------------------------------------------------------------------
------------------------------
* This percentage is based upon the number of Shares issued and outstanding
as of October 31, 2003, as described in RGA's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 2003, as adjusted to give effect to the
public offering by RGA of 10,500,000 Shares (assuming no exercise of the
underwriters' over-allotment option).
Page 6 of 25
SCHEDULE 13D CUSIP No. 759351109
This Statement amends the Schedule 13D Statement, as amended, of
MetLife, Inc., Metropolitan Life Insurance Company, GenAmerica Financial
Corporation, General American Life Insurance Company and Equity Intermediary
Company (collectively, the "Filing Parties") in respect of the common stock of
Reinsurance Group of America, Incorporated, as follows:
Item 3. Source and Amount of Funds or other Consideration.
Item 3 is hereby amended by re-numbering the Exhibits mentioned in the
fourth paragraph from "Exhibits 5, 6 and 7" to "Exhibits 3, 4 and 5" and from
"Exhibits 8, 9 and 10" to "Exhibits 6, 7 and 8".
Item 6. Contracts, Arrangements, Understandings or Relationships With
Respect to Securities of the Issuer.
Item 6 is hereby amended and restated in its entirety as follows:
"In connection with its purchase of the Public Offering Shares, MLINC,
MetLife, GenAm Life and EIM entered into a registration rights agreement with
RGA dated as of November 24, 2003 (the "Registration Rights Agreement"). The
Registration Rights Agreement terminates the prior registration rights
agreements between certain of the Filing Parties and RGA and requires RGA,
following a request, to register the offer and sale of all or any part of the
Public Offering Shares, the Direct Shares, the Indirect Shares and other Shares
which may in the future be acquired by MLINC or its affiliates (the "Future
Shares"). The Registration Rights Agreement also permits the inclusion of all or
part of the Public Offering Shares, the Direct Shares, the Indirect Shares and
the Future Shares in certain other proposed registrations by RGA of its Shares
under the Securities Act of 1933, as amended.
The description of the Registration Rights Agreement set forth in this
Statement is qualified in its entirety by reference to such agreement, included
as Exhibit 10 to this Statement, which is incorporated herein in its entirety by
reference. See also Item 3 above."
Item 7. Material to be Filed as Exhibits.
Item 7 is hereby amended and restated in its entirety as follows:
"Exhibit No. Description
------------ -----------
1 Directors and Executive Officers of Filing Parties
(Incorporated by reference to Exhibit 1 to Amendment No. 5
filed October 24, 2003 ("Amendment No. 5") to the Filing
Parties' Statement on Schedule 13D filed December 3, 1999 (the
"Schedule 13D")
2 Stock Purchase Agreement, dated as of November 23, 1999, by and
between RGA and MetLife (the "RGA Agreement") (Incorporated by
reference to Exhibit 1 to the Schedule 13D)
3 Stock Purchase Agreement, dated as of August 26, 1999, by and
between General American and MetLife (the "General American
Agreement") (Incorporated by reference to Exhibit 2 to the
Schedule 13D)
4 Amendment to General American Agreement, dated as of September
16, 1999, by and between General American and MetLife
(Incorporated by reference to Exhibit 2A to Amendment No. 1
filed January 14, 2000 ("Amendment No. 1") to the Schedule 13D)
5 Second Amendment to General American Agreement, dated as of
January 6, 2000, by and between General American and MetLife
(Incorporated by reference to Exhibit 2B to Amendment No. 1)
6 Commercial Paper Dealer Agreement, dated as of November 24,
1999, between MetLife Funding, Inc. and Deutsche Bank
Securities Inc. (Incorporated by reference to Exhibit 5 to
Amendment No. 1)
7 Commercial Paper Dealer Agreement, dated as of September 24,
1999, between MetLife Funding, Inc. and Chase Securities Inc.
(Incorporated by reference to Exhibit 6 to Amendment No. 1)
8 Section 3(a)(3) Commercial Paper Agreement dated May 13, 1996
between MetLife Funding, Inc. and CS First Boston Corporation
(Incorporated by reference to Exhibit 7 to Amendment No. 1)
9 Agreement Required for Joint Filing under Rule 13d-1(k)(1)
(Incorporated by reference to Exhibit B to Amendment No. 4
filed February 21, 2002 ("Amendment No. 4") to the Schedule
13D)
10 Registration Rights Agreement, dated as of November 24, 2003,
by and among MLINC, MetLife, GenAm Life, EIM and RGA"
Page 7 of 25
SCHEDULE 13D CUSIP No. 759351109
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: November 26, 2003
METLIFE, INC.
By: /s/ Anthony J. Williamson
----------------------------------------------
Name: Anthony J. Williamson
Title: Senior Vice-President and Treasurer
METROPOLITAN LIFE INSURANCE COMPANY
By: /s/ Anthony J. Williamson
----------------------------------------------
Name: Anthony J. Williamson
Title: Senior Vice-President and Treasurer
GENAMERICA FINANCIAL CORPORATION
By: /s/ Anthony J. Williamson
----------------------------------------------
Name: Anthony J. Williamson
Title: Vice-President and Treasurer
GENERAL AMERICAN LIFE INSURANCE COMPANY
By: /s/ Anthony J. Williamson
----------------------------------------------
Name: Anthony J. Williamson
Title: Vice-President and Treasurer
EQUITY INTERMEDIARY COMPANY
By: /s/ Anthony J. Williamson
----------------------------------------------
Name: Anthony J. Williamson
Title: Director, Vice-President and Treasurer
Page 8 of 25